Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03527589 · ClinicalTrials.gov registry record
Embosphere® PROstate Post Market Study
A clinical trial, sponsored by Merit Medical Systems.
- Completed
- Registry status
- 499
- Enrollment target
NCT03527589 is a clinical trial that has completed, run by Merit Medical Systems. The registered enrollment target is 499 participants.
The verdict
NCT03527589 has completed, sponsored by Merit Medical Systems.
- COMPLETED
- Registry status
- 499 participants
- Enrollment target
Study Summary
Prostatic artery embolization with Embosphere Microspheres is a relatively new procedure. The goal of this post market study is to evaluate long-term safety and effectiveness in a 'real world' setting.
Interventions
- DEVICE Prostate artery embolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2018-08-16 |
| Est. Completion | 2022-01-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03527589
The ClinicalTrials.gov registry entry for NCT03527589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merit Medical Systems, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prostate artery embolization is the first listed.
NCT03527589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03527589 about?
NCT03527589 is a clinical study titled "Embosphere® PROstate Post Market Study". Prostatic artery embolization with Embosphere Microspheres is a relatively new procedure. The goal of this post market study is to evaluate long-term safety and effectiveness in a 'real world' setting.
What is the current status of trial NCT03527589?
This trial is currently completed. The enrollment target is 499 participants. The study started on 2018-08-16. Estimated completion is 2022-01-22.
What interventions are being tested in trial NCT03527589?
The interventions under investigation include: Prostate artery embolization (DEVICE).
Who is sponsoring clinical trial NCT03527589?
This trial is sponsored by Merit Medical Systems, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.